| | NETWORK: N00184 | |
Entry |
|
Name |
KSHV MIR1/2 to antigen processing and presentation by MHC class I molecules
|
Definition |
(MIR1,MIR2) -| MHCI |
Expanded |
(K21665,K21666) -| (3105,3106,3107,3133,3134,3135) |
Class |
nt06229 MHC presentation (cancer)
nt06164 Kaposi sarcoma-associated herpesvirus (KSHV)
|
Type |
Pathogen
|
Pathway |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
|
Disease |
|
Gene |
3105 | HLA-A; major histocompatibility complex, class I, A |
3106 | HLA-B; major histocompatibility complex, class I, B |
3107 | HLA-C; major histocompatibility complex, class I, C |
3133 | HLA-E; major histocompatibility complex, class I, E |
3134 | HLA-F; major histocompatibility complex, class I, F |
3135 | HLA-G; major histocompatibility complex, class I, G |
|
Perturbant |
K21665 (MIR1) | MIR1; KSHV E3 ubiquitin-protein ligase MIR1 |
K21666 (MIR2) | MIR2; KSHV E3 ubiquitin-protein ligase MIR2 |
|
Reference |
|
Authors |
Ishido S, Wang C, Lee BS, Cohen GB, Jung JU |
Title |
Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. |
Journal |
|
Reference |
|
Authors |
Liang C, Lee JS, Jung JU |
Title |
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. |
Journal |
|
Reference |
|
Authors |
Schulz TF, Cesarman E |
Title |
Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis. |
Journal |
|
LinkDB |
|
|
|